|
|
|
| Webinar: In vivo CAR-T and gene editing: the manufacturing reality behind the promise | Explore manufacturing realities shaping in vivo CAR-T development in this Lonza webinar. Learn how RNA-LNPs and viral vectors compare under scale-up pressure, where analytical and process challenges emerge, and what separates scalable programs from stalled ones. Through case studies, Lonza experts share lessons learned across both delivery platforms to help teams build stronger manufacturing strategies. Click here to learn more. |
|
|
|
Webinar | Lonza | Discover a decade-long partnership success story that brought two gene therapies to market. See how strategic CDMO collaboration overcomes hurdles in autologous therapy commercialization. |
|
|
|
Video | Cell & Gene | Refine your operational efficiency by focusing on three pillars: inventory, training, and scheduling. Experts discuss actionable improvements to streamline complex cell therapy logistics. |
|
|
|
Webinar | Thermo Fisher Scientific | Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030. |
|
|
|
Webinar | MilliporeSigma | Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments. |
|
|
|
Video | Andelyn Biosciences | Review a framework for identity testing of raw materials in gene therapy. Focus on implementation based on product contact, material classification, and specific manufacturing stages. |
|
|
|
Video | Cell & Gene | Host Erin Harris talks to Tatyana Matveeva, Ph.D., Director of cGMP Operations, about leading cGMP operations in the integrated ecosystem at the George A. "Doc" Lopez, MD Laboratory for Regenerative Cell Therapy, Harvard Medical School and Massachusetts General Hospital, where manufacturing, research, and neurosurgery coexist. |
|
|
| Connect With Cell & Gene: |
|
|
|
